IISc researchers find Asthma drug Montelukast can block crucial SARS-CoV-2 protein - Economic Times

Approved by the US Food and Drug Administration (FDA), the drug, called montelukast, has been around for more than 20 years and is usually prescribed to reduce inflammation caused by conditions like asthma, hay fever and hives.

A drug used to treat asthma and allergies can block a crucial protein produced by the virus SARS-CoV-2, and reduce viral replication in human immune cells, according to a new study by researchers at … [+3508 chars]

full article...